![Paul Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Moore
Chief Tech/Sci/R&D Officer at
ZYMEWORKS INC.
Net worth: 1 M $ as of 2026-08-30
Profile
Paul A. Moore is Chief Scientific Officer at Zymeworks BC, Inc. and Zymeworks, Inc., both positions starting in 2022.
Former roles include Director-Lead Product Development at Human Genome Sciences, Inc., Director-Cell Biology at Celera Corp.
from 2005 to 2008, and Vice President-Cell Biology & Immunology at MacroGenics, Inc. from 2008 to 2022.
Education includes a doctorate from the University of Glasgow and an undergraduate degree from the University of Strathclyde.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZYMEWORKS INC. 0.07% | 2026-01-11 | 48,497 ( 0.07% ) | 1 M $ | 2026-08-30 |
Paul Moore active positions
| Companies | Position | Start |
|---|---|---|
| ZYMEWORKS INC. | Chief Tech/Sci/R&D Officer | 2022-06-30 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Chief Tech/Sci/R&D Officer | 2022-07-17 |
Former positions of Paul Moore
| Companies | Position | End |
|---|---|---|
| MACROGENICS, INC. | Corporate Officer/Principal | 2022-06-30 |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Corporate Officer/Principal | 2008-03-31 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Training of Paul Moore
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Paul Moore
